The Nicotinic Acetylcholine Receptor as a Target for Antidepressant Drug Development

An important new area of antidepressant drug development involves targeting the nicotinic acetylcholine receptor (nAChR). This receptor, which is distributed widely in regions of the brain associated with depression, is also implicated in other important processes that are relevant to depression, su...

Descripción completa

Detalles Bibliográficos
Autores principales: Philip, Noah S., Carpenter, Linda L., Tyrka, Audrey R., Price, Lawrence H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Scientific World Journal 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349306/
https://www.ncbi.nlm.nih.gov/pubmed/22619570
http://dx.doi.org/10.1100/2012/104105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349306/
https://www.ncbi.nlm.nih.gov/pubmed/22619570
http://dx.doi.org/10.1100/2012/104105

Ejemplares similares